KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Clinical trial NCT06193889 · RECRUITING
Trial details
- NCT number
- NCT06193889
- Sponsor
- Kyverna Therapeutics
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-28
- Primary completion
- 2027-09-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.